# A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®

> **NCT03259958** · PHASE1 · COMPLETED · sponsor: **Corium, Inc.** · enrollment: 86 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Donepezil TDS
- **DRUG:** Aricept

## Key facts

- **NCT ID:** NCT03259958
- **Lead sponsor:** Corium, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-30
- **Primary completion:** 2018-03-13
- **Final completion:** 2018-03-14
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03259958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03259958, "A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03259958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*